SCHEMBL14221276

SCHEMBL14221276

O=c1c(Cl)c(-n2ccnc2)cnn1-c1cccc(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 3/20 0.59
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ PKM P14618 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ POLB P06746 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ PPARG P37231 1/20 0.47
▸ NCOA2 Q15596 1/20 0.47
▸ NCOA1 Q15788 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ NCOA3 Q9Y6Q9 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ PAX8 Q06710 2/20 0.46
▸ MEN1 O00255 1/20 0.43
▸ NPBWR1 P48145 1/20 0.43
▸ MCHR1 Q99705 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14220860 0.89 IDO1 (0.46) IDO1SMN1; SMN2PKMKMT2APOLB
SCHEMBL14221370 0.88 ALDH1A1 (0.56) IDO1SMN1; SMN2KMT2ACYP3A4CYP2C19
SCHEMBL14282207 0.86 NPBWR1 (0.48) IDO1SMN1; SMN2KMT2APOLBCYP3A4
SCHEMBL14282209 0.86 NOTUM (0.54) IDO1SMN1; SMN2KMT2ACYP3A4ALDH1A1
SCHEMBL14282208 0.81 RAB9A (0.53) SMN1; SMN2KMT2ACYP3A4CYP2C19PPARG
SCHEMBL14282213 0.81 CYP17A1 (0.56) SMN1; SMN2PKMKMT2APOLBCYP3A4
SCHEMBL14282212 0.80 GAA (0.48) IDO1SMN1; SMN2KMT2ACYP3A4CYP2C19
SCHEMBL14282211 0.78 NPBWR1 (0.46) SMN1; SMN2KMT2ACYP3A4NPSR1ALDH1A1
SCHEMBL14282214 0.77 SMN1; SMN2 (0.43) SMN1; SMN2KMT2AALDH1A1NPC1RAB9A
SCHEMBL710352 0.76 IDO1 (1.00) IDO1KMT2ACYP3A4NCOA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497269-B1 SUBSTITUTED 2-PHENYL-3(2H)-PYRIDAZINONES BAYER HEALTHCARE AG (DE) 2008-04-23 — — EP disclosed
US-7320977-B2 Fibrotic disorders; disorders characterized by harmful buildup of collagen and/or by excessive lysyl oxidase enzymatic activity BAYER HEALTHCARE AG (DE) 2008-01-22 — — US disclosed
US-7320977-B2 Fibrotic disorders; disorders characterized by harmful buildup of collagen and/or by excessive lysyl oxidase enzymatic activity BAYER HEALTHCARE AG (DE) 2008-01-22 — — US disclosed
Send feedback